Matches in Wikidata for { <http://www.wikidata.org/entity/Q91703157> ?p ?o ?g. }
Showing items 1 to 54 of
54
with 100 items per page.
- Q91703157 description "article scientifique publié en 2017" @default.
- Q91703157 description "artículu científicu espublizáu en setiembre de 2017" @default.
- Q91703157 description "scientific article published on 09 September 2017" @default.
- Q91703157 description "wetenschappelijk artikel" @default.
- Q91703157 description "наукова стаття, опублікована у вересні 2017" @default.
- Q91703157 name "Sustained Benefits from Ranibizumab for Central Retinal Vein Occlusion with Macular Edema: 24-Month Results of the CRYSTAL Study" @default.
- Q91703157 name "Sustained Benefits from Ranibizumab for Central Retinal Vein Occlusion with Macular Edema: 24-Month Results of the CRYSTAL Study" @default.
- Q91703157 type Item @default.
- Q91703157 label "Sustained Benefits from Ranibizumab for Central Retinal Vein Occlusion with Macular Edema: 24-Month Results of the CRYSTAL Study" @default.
- Q91703157 label "Sustained Benefits from Ranibizumab for Central Retinal Vein Occlusion with Macular Edema: 24-Month Results of the CRYSTAL Study" @default.
- Q91703157 prefLabel "Sustained Benefits from Ranibizumab for Central Retinal Vein Occlusion with Macular Edema: 24-Month Results of the CRYSTAL Study" @default.
- Q91703157 prefLabel "Sustained Benefits from Ranibizumab for Central Retinal Vein Occlusion with Macular Edema: 24-Month Results of the CRYSTAL Study" @default.
- Q91703157 P1433 Q91703157-F44E5ADC-463F-442C-AD72-3F8BEEA2A5E6 @default.
- Q91703157 P1476 Q91703157-9F645B7D-45B0-4453-8CF3-30C9F183D3AE @default.
- Q91703157 P2093 Q91703157-152D040A-1AF5-4D0C-9F81-EE2FA2EE8441 @default.
- Q91703157 P2093 Q91703157-1FBD99D0-8746-4935-BF7D-B1323A98A981 @default.
- Q91703157 P2093 Q91703157-2A701748-7CAA-4337-B329-4692546C2273 @default.
- Q91703157 P2093 Q91703157-5E0139EA-D28B-4EE6-8B77-C97FC1E7A713 @default.
- Q91703157 P2093 Q91703157-6297B4FB-AC82-4E91-BDE3-337E618D00AB @default.
- Q91703157 P2093 Q91703157-80E8EE0A-1E44-4DE2-9480-F83A41C90205 @default.
- Q91703157 P2093 Q91703157-8DCEF222-943A-4929-A4AC-2CAFC00D39B3 @default.
- Q91703157 P2093 Q91703157-939CCE45-E070-42BF-81D1-9A0714CD66EA @default.
- Q91703157 P2093 Q91703157-B9BCA9C8-CAE5-43C0-9F8B-B88B5D8E613F @default.
- Q91703157 P2093 Q91703157-C8B3C2FF-6103-4628-AF80-BFD644C3B103 @default.
- Q91703157 P304 Q91703157-67F8F186-69C9-427E-81F9-5C282B6E0EEE @default.
- Q91703157 P31 Q91703157-CF2D9EB0-50DA-4042-9671-D48E5D0DA5FB @default.
- Q91703157 P356 Q91703157-F99919E7-7835-4F2D-88DE-2A20F3B16940 @default.
- Q91703157 P433 Q91703157-CA904F8C-7C83-4800-84C3-8CC6C88FFF70 @default.
- Q91703157 P478 Q91703157-10ECBF14-67FB-4946-872B-BAE43DE89E94 @default.
- Q91703157 P577 Q91703157-F76BB1EB-4459-4FA3-BA1A-2A25A94EAA04 @default.
- Q91703157 P698 Q91703157-65A0ED20-3BC1-4133-81BB-36D9DFF98AC8 @default.
- Q91703157 P921 Q91703157-A226DB85-0A6E-4A36-8B34-D32ACFD547D1 @default.
- Q91703157 P356 J.ORET.2017.05.016 @default.
- Q91703157 P698 31047340 @default.
- Q91703157 P1433 Q63241478 @default.
- Q91703157 P1476 "Sustained Benefits from Ranibizumab for Central Retinal Vein Occlusion with Macular Edema: 24-Month Results of the CRYSTAL Study" @default.
- Q91703157 P2093 "Andreas Wenzel" @default.
- Q91703157 P2093 "Ayan Das Gupta" @default.
- Q91703157 P2093 "CRYSTAL Study Group" @default.
- Q91703157 P2093 "Elizabeth Barnes" @default.
- Q91703157 P2093 "Jordi Monés" @default.
- Q91703157 P2093 "Margarita Gekkieva" @default.
- Q91703157 P2093 "Michael Larsen" @default.
- Q91703157 P2093 "Philip Hykin" @default.
- Q91703157 P2093 "Sebastian M Waldstein" @default.
- Q91703157 P2093 "Siegfried Priglinger" @default.
- Q91703157 P304 "134-142" @default.
- Q91703157 P31 Q13442814 @default.
- Q91703157 P356 "10.1016/J.ORET.2017.05.016" @default.
- Q91703157 P433 "2" @default.
- Q91703157 P478 "2" @default.
- Q91703157 P577 "2017-09-09T00:00:00Z" @default.
- Q91703157 P698 "31047340" @default.
- Q91703157 P921 Q190831 @default.